Lesotho vs Togo: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Lesotho
1.4%
in 2024
Togo
1.4%
in 2024
Lesotho rank
20th
Togo rank
20th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Lesotho
- Togo
How they compare
Lesotho currently reports 1.4% against 1.4% in Togo, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Lesotho ahead.
Lesotho ranks 20th and Togo ranks 20th of 215 countries.
Lesotho has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lesotho | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.3% | 1.9% | 1.4% | Lesotho |
| 2020s | 1.8% | 1.5% | 0.2% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Lesotho or Togo?
- Lesotho, at 1.4% against 1.4% in Togo as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Lesotho and Togo?
- 0.0%, with Lesotho ahead.
- How many years of comparable data are there for Lesotho and Togo?
- 10 years are reported by both, from 2015 to 2024.
- How do Lesotho and Togo rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Lesotho ranks 20th and Togo ranks 20th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.